Cited by 719RNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryDendrimers and Hyperbranched Polymers

Nanodelivery of nucleic acids

Open access
Mendes, Bárbara B., Conniot, João, Avital, Aviram, Yao, Dongbao, Jiang, Xingya, Zhou, Xiang, Sharf-Pauker, Noga, Xiao, Yuling +5 more·2022·Nature Reviews Methods Primers

Abstract

There is growing need for a safe, efficient, specific and non-pathogenic means for delivery of gene therapy materials. Nanomaterials for nucleic acid delivery offer an unprecedented opportunity to overcome these drawbacks; owing to their tunability with diverse physico-chemical properties, they can readily be functionalized with any type of biomolecules/moieties for selective targeting. Nucleic acid therapeutics such as antisense DNA, mRNA, small interfering RNA (siRNA) or microRNA (miRNA) have been widely explored to modulate DNA or RNA expression Strikingly, gene therapies combined with nanoscale delivery systems have broadened the therapeutic and biomedical applications of these molecules, such as bioanalysis, gene silencing, protein replacement and vaccines. Here, we overview how to design smart nucleic acid delivery methods, which provide functionality and efficacy in the layout of molecular diagnostics and therapeutic systems. It is crucial to outline some of the general design considerations of nucleic acid delivery nanoparticles, their extraordinary properties and the structure-function relationships of these nanomaterials with biological systems and diseased cells and tissues.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s43586-022-00104-y

Cites

230 of 230 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Modulation of surface characteristics may help to improve transduction and reduce the dose required, thereby reducing the risk of GTAU.

    “Modulation of surface characteris­ tics may help to improve transduction and reduce the dose required, thereby reducing the risk of GTAU (Mendes et al., 2022; Carvalho et al., 2023).”

    From Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy (2025) · cites this paper as Mendes et al., 2022

    The Targeting section (page unavailable) says surface chemistry and surface-conjugated ligands can increase nanomaterials’ affinity for specific cells or tissues, supporting the delivery-improvement part of the claim. The cited passages do not establish that such changes reduce the required dose or the risk of GTAU; searches for uveitis, dose reduction, and surface modification did not find that link in our copy. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Mendes, B. B., Conniot, J., Avital, A., Yao, D., Jiang, X., Zhou, X., Sharf-Pauker, N., Xiao, Y., Adir, O., Liang, H., Shi, J., Schroeder, A., & Conde, J.
Affiliations
  • Ningbo University (CN)
  • University of Science and Technology of China (CN)
  • Brigham and Women's Hospital (US)
  • Technion – Israel Institute of Technology (IL)
  • Universidade Nova de Lisboa (PT)
Corresponding author
  • Liang, Haojun
  • Shi, Jinjun
  • Schroeder, Avi
  • Conde, João
Venue
Nature Reviews Methods Primers
Published
2022-04-14
Volume
2
Issue
1
ISSN
2662-8449 (ISSN-L)
OpenAlex
W4223968391
Cited by
719
References
230
Citations by year
2026: 166 · 2025: 233 · 2024: 196 · 2023: 103 · 2022: 21
FWCI
14.40
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Methods Primers (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
Funders
  • U.S. Department of Veterans Affairs (I01 BX004426)
  • American Lung Association
  • Massachusetts General Hospital
  • National Natural Science Foundation of China (52003264, 21991132, 52033010, 2020YFA0710700, 52021002)
  • National Institutes of Health
  • Fundação para a Ciência e a Tecnologia (PTDC/BTM-MAT/4738/2020)
  • Fundamental Research Funds for the Central Universities
  • National Heart, Lung, and Blood Institute (R01HL159012, R01HL156362, R01HL137229, R01HL158097, R01HL162367)
  • National Cancer Institute (R01CA200900)
  • H2020 European Research Council (848325)
  • DOD Peer Reviewed Cancer Research Program
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
Keywords
nucleic acid delivery, nanodelivery, gene therapy, nanoparticles, siRNA, microRNA, antisense DNA, mRNA therapeutics, targeted delivery, structure-function relationship, molecular diagnosis, gene silencing, vaccines, protein replacement

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review